3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Urinary Bladder Neoplasms
2
Hyperthermia
2
Ureteral Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Retinoblastoma
1
Oropharyngeal Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
Magnetic Resonance Spectroscopy
8
Specimen Handling
7
Cisplatin
7
Surgical Procedures, Operative
5
pembrolizumab
3
Radiotherapy, Intensity-Modulated
3
Platinum
3
Chemoradiotherapy
3
Cetuximab
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
Radiotherapy
2
Radiation
2
Interviews as Topic
2
Docetaxel
2
toripalimab
1
sacituzumab govitecan
1
merphos
1
ipatasertib
1
cabozantinib
1
X-Rays
1
Tretinoin
1
Surveys and Questionnaires
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Practice Guidelines as Topic
1
Nivolumab
1
Neoadjuvant Therapy
1
Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Hypopharyngeal Neoplasms
×
Hyperthermia, Induced
×
Clear all
NCT06761937
2025-07-25
TANCA-I
Erasmus Medical Center
Phase 1
Recruiting
30 enrolled